Clearance Summary
BIOTIS ABNORMAL CLINICAL CHEM SERUM- received FDA 510(k) clearance under submission number K840458, sponsored by Otisville Biotech, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1984-04-17.
- Submission: K840458
- Applicant / Sponsor: Otisville Biotech, Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1660
- Decision date: 1984-04-17
Classification & Regulation
This clearance is catalogued under FDA product code JJY and 21 CFR 862.1660, within the Clinical Chemistry review panel as a Class I device.